At the end of the treatment period, the TGCT tumors were excised from the CAM and histological examination of the proliferation marker Ki67 was performed showing the reduced proliferative activity of animacroxam‐treated tumor cells (Fig. 1F,G). Here, MKI67 is linked to neoplasm.